Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development
Epilepsy is a serious neurological disorder that affects around 50 million people worldwide. Almost 30% of epileptic patients suffer from pharmacoresistance, which is associated with social isolation, dependent behaviour, low marriage rates, unemployment, psychological issues and reduced quality of...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/7/2090/ |